More Company News

ANGLE

Repeat Pharma Services business
22 Jun 2022Read More

ANGLE

Predicting immunotherapy response in SCLC
16 Jun 2022Read More

ANGLE

Potential role of invasive cellular protrusions
14 Jun 2022Read More

ANGLE

Partnership with major US urology group
30 May 2022Read More

ANGLE

Molecular characterisation of CTCs
27 May 2022Read More

ANGLE

FDA clearance for Parsortix
25 May 2022Read More

ANGLE

Prostate Cancer UK funds new study
20 May 2022Read More

ANGLE

FY21 results
28 Apr 2022Read More

ANGLE

Parsortix poster presented at AACR
14 Apr 2022Read More

ANGLE

Identifying drug targets in cancer metastasis
01 Apr 2022Read More

1 2 3 4
Return to ANGLE
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).